In-depth analysis of pneumococcal serotypes in Belgian children (2015–2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- Fonds Wetenschappelijk Onderzoek
This publication has 24 references indexed in Scilit:
- Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in BelgiumVaccine, 2019
- Pneumococcal Vaccines: Host Interactions, Population Dynamics, and Design PrinciplesAnnual Review of Microbiology, 2018
- Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?The Lancet Infectious Diseases, 2018
- Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15The Lancet Global Health, 2018
- Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literatureVaccine, 2017
- Decreased Carriage and Genetic Shifts in the Streptococcus pneumoniae Population After Changing the Seven-valent to the Thirteen-valent Pneumococcal Vaccine in NorwayThe Pediatric Infectious Disease Journal, 2015
- Pneumococcal Capsules and Their Types: Past, Present, and FutureClinical Microbiology Reviews, 2015
- Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort studyThe Lancet Infectious Diseases, 2011
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesThe Lancet, 2009
- Streptococcus pneumoniae colonisation: the key to pneumococcal diseaseThe Lancet Infectious Diseases, 2004